BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3524894)

  • 21. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis.
    Karwande SV; Weksler BB; Gay WA; Subramanian VA
    Ann Thorac Surg; 1987 Mar; 43(3):318-22. PubMed ID: 3548616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
    Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
    Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
    [No Abstract]   [Full Text] [Related]  

  • 23. Beneficial effects of ibuprofen in pacing-induced myocardial ischemia.
    Walinsky P; Smith JB; Lefer AM; Wiener L
    Am J Cardiol; 1983 Mar; 51(5):751-4. PubMed ID: 6829434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediation of cardiac ischemia by thromboxanes released from human platelets.
    Addonizio VP; Wetstein L; Fisher CA; Feldman P; Strauss JF; Harken AH
    Surgery; 1982 Aug; 92(2):292-8. PubMed ID: 7048597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Amrinone, a cardiotonic drug, on hemodynamics and platelet function.
    Rao GH; Einzig S; Johnson GJ; White JG
    Prostaglandins Med; 1981 Jan; 6(1):51-64. PubMed ID: 6784136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
    Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
    Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A monoclonal anti-thromboxane B2 antibody.
    Reinke M; Brune K
    FEBS Lett; 1988 May; 232(1):46-50. PubMed ID: 3130275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective actions of ibuprofen in arachidonate-induced sudden death.
    Roth DM; Burke SE; Lefer AM
    Pharmacology; 1983; 27(3):169-75. PubMed ID: 6413987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of ibuprofen effect on platelet and endothelial prostanoid release.
    Longenecker GL; Swift IA; Bowen RJ; Beyers BJ; Shah AK
    Clin Pharmacol Ther; 1985 Mar; 37(3):343-8. PubMed ID: 3882308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation and thromboxane B2 release in patients with acute myocardial infarction--their relation to coronary patency.
    Takatsu Y; Yui Y; Hattori R; Sakaguchi K; Susawa T; Yui N; Takahashi M; Aoyama T; Tamaki S; Kawai C
    Jpn Circ J; 1988 Apr; 52(4):314-20. PubMed ID: 3385913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin and thromboxane in gynecology and obstetrics.
    Ylikorkala O; Mäkilä UM
    Am J Obstet Gynecol; 1985 Jun; 152(3):318-29. PubMed ID: 3890549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ethanol on thromboxane and prostacyclin synthesis by fetal platelets and umbilical artery.
    Ylikorkala O; Halmesmäki E; Viinikka L
    Life Sci; 1987 Jul; 41(3):371-6. PubMed ID: 3110528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.
    Addonizio VP; Fisher CA; Jenkin BK; Strauss JF; Musial JF; Edmunds LH
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):926-33. PubMed ID: 2582210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.
    Montalescot G; Drobinski G; Maclouf J; Maillet F; Salloum J; Ankri A; Kazatchkine M; Eugène L; Thomas D; Grosgogeat Y
    Circulation; 1991 Nov; 84(5):2054-62. PubMed ID: 1934381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 9 beta-methylcarbacyclin, a stable prostacyclin analogue, in prevention of platelet losses during charcoal haemoperfusion.
    Hughes RD; Langley PG; Guarner F; Williams R
    J Pharm Pharmacol; 1986 Jan; 38(1):63-5. PubMed ID: 2869131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet and blood vessel arachidonate metabolism and interactions.
    Needleman P; Wyche A; Raz A
    J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.